Genomic Vision S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,226.00
22,764.00
15,593.00
6,886.00
2,027.00
3,172
Total Accounts Receivable
1,390.00
2,112.00
2,773.00
2,983.00
2,663.00
2,224
Inventories
72.00
134.00
118.00
571.00
1,448.00
1,890
Other Current Assets
127.00
119.00
370.00
244.00
237.00
143
Total Current Assets
4,815.00
25,129.00
18,854.00
10,684.00
6,375.00
7,429
Net Property, Plant & Equipment
790.00
871.00
2,632.00
2,113.00
1,465.00
908
Total Investments and Advances
85.00
184.00
189.00
195.00
217.00
-
Intangible Assets
111.00
260.00
262.00
226.00
173.00
140
Other Assets
-
-
-
-
49.00
212
Total Assets
5,801.00
26,444.00
21,937.00
13,218.00
8,279.00
8,689
ST Debt & Current Portion LT Debt
770.00
770.00
22.00
-
930.00
Accounts Payable
896.00
828.00
1,231.00
1,106.00
1,540.00
Income Tax Payable
64.00
59.00
71.00
89.00
95.00
Other Current Liabilities
2,116.00
1,782.00
1,971.00
1,768.00
1,449.00
Total Current Liabilities
3,846.00
3,439.00
3,295.00
2,963.00
4,014.00
Long-Term Debt
54.00
22.00
-
-
-
Provision for Risks & Charges
68.00
86.00
81.00
92.00
370.00
Other Liabilities
851.00
202.00
178.00
128.00
138.00
Total Liabilities
4,819.00
3,749.00
3,554.00
3,183.00
4,522.00
Common Equity (Total)
982.00
22,695.00
18,383.00
10,035.00
3,757.00
Total Shareholders' Equity
982.00
22,695.00
18,383.00
10,035.00
3,757.00
Total Equity
982.00
22,695.00
18,383.00
10,035.00
3,757.00
Liabilities & Shareholders' Equity
5,801.00
26,444.00
21,937.00
13,218.00
8,279.00

About Genomic Vision

View Profile
Address
Green Square
Bagneux Ile-de-France 92220
France
Employees -
Website http://www.genomicvision.com
Updated 07/08/2019
GĂ©nomic Vision SA is a molecular diagnostics and technology company, which engages in the development of single DNA detection tools for research and in vitro diagnostics. The firm's products include molecular combing platform and genomic morse code sets. It provides molecular diagnostics, genetic testing services and cancer research programs.